Post Views: 37 Share via: Facebook X (Twitter) LinkedIn More Xiaorong JI View All Posts Post navigation Previous Post Dr. Jie Jin: the New JAK Inhibitor Jaktinib in the Treatment of Myelofibrosis (MF)Next PostClinical management, scientific research priorities and future action plan of MASLD